Integrity
|
||||||
|
Zoonotic Diseases Viral Diseases - KYASANUR FOREST DISEASE Kyasanur Forest Disease was first recognized in 1957 during a fatal epizootic of wild monkeys in Mysore (Karnataka), India. Forest workers are particularly at risk, and mortality may reach 10%. The causative virus is a tick-borne virus belonging to the genus Flavivirus of the family Flaviviridae, which has been isolated from ticks, monkeys, and humans. The principal vector appears to be the tick Haemaphysalis spinigera, whereas the vertebrate reservoir is uncertain. Manifestations: The symptoms are:
Diagnose and treatment: There is no
specific treatment for the disease.
Vaccination: The vaccine available
for control of Kyasanur forest disease is an inactivated virus
vaccine.
Prevent Kyasanur forest disease by:
GENERAL: In most man is an accidental host
infected when arthropods feed on him. Therefore quarantine of wild caught
animals and elimination of ectoparasites should prevent: (2.) MOSQUITO BORNE viruses: (c) CRIMEAN CONGO HEMORRHAGIC FEVER. Nairovirus, Bunyaviridae family. Causes epidemics in Bulgaria, USSR, and sporadic cases in Iraq, Pakistan and East Africa. Associated with tick bites, primarily Hyalomma genus. Also nosocomial outbreaks among hospital personnel. (d) OMSK HEMORRHAGIC FEVER (rodents) (e) KYASANUR FOREST DISEASE (monkeys) Togaviridae occurs in bonnet macaques, languors, and rodents in India spread by ticks lab workers in the US affected while working with infected primates (no vector) NHP exhibit fever, vomiting, diarrhea, epistaxis, and death. In humans, there is a sudden onset of fever which may be biphasic, with headache, generalized pains, prostration, conjunctivitis, diarrhea, and vomiting. Vesicles occur on the soft palate. Hemorrhagic manifestations may follow. Case fatality rate is 2-50%. Diagnosed thru serology or viral isolation. Treatment is supportive. Convalescent plasma with a high neutralizing antibody titer has been reported to be useful. Prevention is thru tick control. (f) CHIKUNGUNYA: Maintained by vervets and baboons in Southern Africa. Transmitted by biting flies and mosquitoes (g) RIFT VALLEY FEVER (Enzootic Hepatitis) AGENT:Phlebovirus, Bunyaviridae RESERVOIR AND INCIDENCE:Endemic in Africa and Egypt. Affects nonhuman primates, and man. Cattle, bats, and sheep may be reservoir hosts. TRANSMISSION:Mosquito vector highly contagious among laboratory workers where transmission does not require vector. DISEASE IN ANIMALS:Rapid death after fever occurs in lambs. In cattle abortion and diarrhea occur. Liver lesions predominate histologically, with areas of necrosis. Widespread hemorrhages occur. DISEASE IN MAN:Fever (which may be biphasic) has a sudden onset, with severe headache, muscle and joint pains and photophobia. In a small proportion of cases there are hemorrhages, liver necrosis, encephalitis and retinitis. DIAGNOSIS:Serology and virus isolation. PREVENTION/CONTROL:Control mosquitoes. Precaution in handling necropsy specimens. Arbovirus where the natural cycle of transmission DOES involve man.
|